Skip to main content
Clinical Trials/NCT04319289
NCT04319289
Completed
Not Applicable

Effect of Aerobic Interval Training Combined With Vitamin D Supplement on Functional Capacity and Perceived Myalgia in Middle Aged Obese Women

Cairo University1 site in 1 country45 target enrollmentJanuary 12, 2020

Overview

Phase
Not Applicable
Intervention
aerobic interval training and Vitamin D supplementation,
Conditions
Vitamin D Deficiency
Sponsor
Cairo University
Enrollment
45
Locations
1
Primary Endpoint
Description of Functional capacity efficiency
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

This study aimed to investigate whether there will be an effect of adding a program of aerobic interval training in managing patients suffering from myalgia associated with vitamin D deficiency.

Detailed Description

Forty five women complaining from myalgia with vitamin D deficiency participating in this study. Their ages are ranged from 30 to 40 years. They are assigned randomly into three groups: * Group (A): included 15 patients who are participating in an aerobic interval training exercise program with vitamin D supplementation (cholecalciferol 400 IU/day). * Group (B): included 15 patients who are receiving vitamin D supplementation only (cholecalciferol 400 IU/day). * Group (C): included 15 patients who are participating in an interval training exercise program only. The intervention will last for 12 weeks

Registry
clinicaltrials.gov
Start Date
January 12, 2020
End Date
May 20, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Heba Ahmed Ali Abdeen

Assistant professor, Faculty of Physical Therapy

Cairo University

Eligibility Criteria

Inclusion Criteria

  • Forty five sedentry women with non specific myalgia pain.
  • The patients' ages ranged from 30 -40 years.
  • All patients have non specific muscle pain for more than 2 months.
  • They have vitamin D deficiency.
  • All patients have BMI from 25 to 34.9 kg/m
  • All patients were clinically and medically stable when attending the study.

Exclusion Criteria

  • Unstable cardiovascular and chest problems.
  • Patients with diseases which affect vitamin D level as a history of rheumatic or metabolic bone diseases and diabetes.
  • Patients taking drugs which affect vitamin D level as steroids and anticonvulsants drugs .
  • Musculoskeletal disorders which may affect their physical ability to do the exercises.

Arms & Interventions

Group (A)

Included 15 patients who are participating in an aerobic interval training exercise program with vitamin D supplementation (cholecalciferol 400 IU/day). The aerobic interval training is conducted for one hour, three days per week on a total period of 12 weeks.

Intervention: aerobic interval training and Vitamin D supplementation,

Group (B)

Included 15 patients who are receiving vitamin D supplementation only . One capsule containing (cholecalciferol 400 IU) was taken every day for 12 weeks

Intervention: Vitamin D supplementation only

Group (c)

Included 15 patients who are participating in an aerobic interval training exercise program only. The aerobic interval training is conducted for one hour, three days per week on a total period of 12 weeks.

Intervention: aerobic interval training only

Outcomes

Primary Outcomes

Description of Functional capacity efficiency

Time Frame: It is performed before and after the study(12 weeks interval) for all groups

Cooper 12-Minute Walk Test (12MWT)

Intensity of non specific muscle pain (myalgia)

Time Frame: It is performed before and after the study(12 weeks interval) for all groups

A 10-cm Visual Analogue Scale (VAS) was used to evaluate the patients' pain , with 0 representing no pain and 10 representing the worst pain imaginable

Description of the improvement in Quality of life

Time Frame: It is performed before and after the study(12 weeks interval) for all groups

The Short form health survey (SF-12)is often used to compare health status between groups of patients, to indentify predictors of health status

Concentration of Plasma Serum vitamin D level (25OHD)

Time Frame: It is performed before and after the study(12 weeks interval) for all groups

It is performed by Laboratory BioPlex® 2200 System

Study Sites (1)

Loading locations...

Similar Trials